Skip to main content
Signal8

Vessey Rupert

SEC insider (Form 3/4/5 filer). CIK 0001677618. Director at Generate Biomedicines, Inc. (GENB) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in SOMERVILLE, MA.

Companies Vessey Rupert has filed insider reports for

  • Generate Biomedicines, Inc. (GENB): Director
  • BIO-TECHNE Corp (TECH): Director
Vessey Rupert profile photo

Vessey Rupert

CIK: 0001677618

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Generate Biomedicines, Inc. logo
GENB

Generate Biomedicines, Inc.

Director
BIO-TECHNE Corp logo
TECH

BIO-TECHNE Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Generate Biomedicines, Inc. logo
    GENB

    Generate Biomedicines, Inc.

    Feb 26, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    29.6K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Oct 30, 2025
    Award
    Direct
    1.6K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Oct 24, 2024
    Award
    Direct
    1.5K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Jul 1, 2019
    Award

    Stock Options (Right to Buy)

    Direct
    588 shares-

1-4 of 4